Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Filter articles using the following links
Financial press releases
Events & presentations
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
10 Aug 2017
Ophthalmology Innovation Summit @ ASRS, Boston (MA)
01 August 2017
GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy
28 July 2017
GenSight Biologics Reports Interim Financial Results for the First Half of 2017
23 June 2017
Publication of the securities note having obtained visa no. 17-297 of the AMF in connection with the capital increase of GenSight Biologics
23 June 2017
GenSight Biologics successfully raises €22.5 million from leading investors in the US and Europe
22 June 2017
GenSight Biologics launches a capital increase of approximately €20 million
19 Jun 2017 - 22 Jun 2017
BIO International Convention, San Diego, CA (US)
14 June 2017
GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
30 May 2017
15ème Forum Santé Gilbert Dupont, Paris (France)
28 May 2017 - 31 May 2017
ISCAS 2017, Baltimore, Maryland (US)
View previous 9 articles
1
…
27
28
29
30
31
32
33
34
35
36
37
…
40
View next 9 articles
Go back to the page of the page